nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.126	0.174	CrCrCtD
Disopyramide—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.126	0.174	CrCrCtD
Disopyramide—Doxylamine—Tamoxifen—pancreatic cancer	0.109	0.15	CrCrCtD
Disopyramide—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.103	0.143	CrCrCtD
Disopyramide—Tripelennamine—Tamoxifen—pancreatic cancer	0.0984	0.136	CrCrCtD
Disopyramide—Methadone—Tamoxifen—pancreatic cancer	0.0864	0.119	CrCrCtD
Disopyramide—Clofedanol—Tamoxifen—pancreatic cancer	0.0747	0.103	CrCrCtD
Disopyramide—ORM1—Erlotinib—pancreatic cancer	0.0728	0.608	CbGbCtD
Disopyramide—CYP3A4—Tamoxifen—pancreatic cancer	0.0113	0.0942	CbGbCtD
Disopyramide—CYP3A4—Erlotinib—pancreatic cancer	0.0096	0.0801	CbGbCtD
Disopyramide—CYP3A4—Irinotecan—pancreatic cancer	0.00867	0.0724	CbGbCtD
Disopyramide—CYP3A4—Docetaxel—pancreatic cancer	0.00636	0.053	CbGbCtD
Disopyramide—CYP3A4—Sunitinib—pancreatic cancer	0.00633	0.0528	CbGbCtD
Disopyramide—CYP3A4—Doxorubicin—pancreatic cancer	0.00474	0.0395	CbGbCtD
Disopyramide—ORM1—bile—pancreatic cancer	0.00188	0.448	CbGeAlD
Disopyramide—KCND3—islet of Langerhans—pancreatic cancer	0.000625	0.149	CbGeAlD
Disopyramide—ORM1—gall bladder—pancreatic cancer	0.000522	0.124	CbGeAlD
Disopyramide—KCND3—pancreas—pancreatic cancer	0.000439	0.105	CbGeAlD
Disopyramide—SLC22A2—digestive system—pancreatic cancer	0.000267	0.0634	CbGeAlD
Disopyramide—Hepatitis—Docetaxel—pancreatic cancer	0.000242	0.00203	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000241	0.00202	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—pancreatic cancer	0.000241	0.00202	CcSEcCtD
Disopyramide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000241	0.00202	CcSEcCtD
Disopyramide—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00024	0.00202	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.00024	0.00201	CcSEcCtD
Disopyramide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00024	0.00201	CcSEcCtD
Disopyramide—Confusional state—Fluorouracil—pancreatic cancer	0.00024	0.00201	CcSEcCtD
Disopyramide—Body temperature increased—Sunitinib—pancreatic cancer	0.000238	0.002	CcSEcCtD
Disopyramide—Diarrhoea—Erlotinib—pancreatic cancer	0.000238	0.002	CcSEcCtD
Disopyramide—Oedema—Fluorouracil—pancreatic cancer	0.000238	0.00199	CcSEcCtD
Disopyramide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000237	0.00199	CcSEcCtD
Disopyramide—Anorexia—Irinotecan—pancreatic cancer	0.000237	0.00198	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—pancreatic cancer	0.000235	0.00197	CcSEcCtD
Disopyramide—Skin disorder—Gemcitabine—pancreatic cancer	0.000235	0.00197	CcSEcCtD
Disopyramide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000234	0.00196	CcSEcCtD
Disopyramide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000233	0.00195	CcSEcCtD
Disopyramide—Dizziness—Tamoxifen—pancreatic cancer	0.000233	0.00195	CcSEcCtD
Disopyramide—Hypotension—Irinotecan—pancreatic cancer	0.000232	0.00195	CcSEcCtD
Disopyramide—Anorexia—Gemcitabine—pancreatic cancer	0.00023	0.00193	CcSEcCtD
Disopyramide—Dizziness—Erlotinib—pancreatic cancer	0.00023	0.00193	CcSEcCtD
Disopyramide—Anorexia—Fluorouracil—pancreatic cancer	0.000227	0.0019	CcSEcCtD
Disopyramide—Hypotension—Gemcitabine—pancreatic cancer	0.000226	0.00189	CcSEcCtD
Disopyramide—SCN5A—digestive system—pancreatic cancer	0.000225	0.0536	CbGeAlD
Disopyramide—Insomnia—Irinotecan—pancreatic cancer	0.000225	0.00188	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—pancreatic cancer	0.000224	0.00188	CcSEcCtD
Disopyramide—Vomiting—Tamoxifen—pancreatic cancer	0.000224	0.00188	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000223	0.00187	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—pancreatic cancer	0.000223	0.00187	CcSEcCtD
Disopyramide—Paraesthesia—Irinotecan—pancreatic cancer	0.000223	0.00187	CcSEcCtD
Disopyramide—Hypotension—Fluorouracil—pancreatic cancer	0.000222	0.00186	CcSEcCtD
Disopyramide—Rash—Tamoxifen—pancreatic cancer	0.000222	0.00186	CcSEcCtD
Disopyramide—Dermatitis—Tamoxifen—pancreatic cancer	0.000222	0.00186	CcSEcCtD
Disopyramide—Vomiting—Erlotinib—pancreatic cancer	0.000221	0.00186	CcSEcCtD
Disopyramide—Dyspnoea—Irinotecan—pancreatic cancer	0.000221	0.00186	CcSEcCtD
Disopyramide—Somnolence—Irinotecan—pancreatic cancer	0.000221	0.00185	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000221	0.00185	CcSEcCtD
Disopyramide—Headache—Tamoxifen—pancreatic cancer	0.00022	0.00185	CcSEcCtD
Disopyramide—Rash—Erlotinib—pancreatic cancer	0.000219	0.00184	CcSEcCtD
Disopyramide—Dermatitis—Erlotinib—pancreatic cancer	0.000219	0.00184	CcSEcCtD
Disopyramide—Insomnia—Gemcitabine—pancreatic cancer	0.000219	0.00183	CcSEcCtD
Disopyramide—Dyspepsia—Irinotecan—pancreatic cancer	0.000218	0.00183	CcSEcCtD
Disopyramide—Headache—Erlotinib—pancreatic cancer	0.000218	0.00183	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—pancreatic cancer	0.000218	0.00183	CcSEcCtD
Disopyramide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000217	0.00182	CcSEcCtD
Disopyramide—Asthenia—Sunitinib—pancreatic cancer	0.000216	0.00181	CcSEcCtD
Disopyramide—Decreased appetite—Irinotecan—pancreatic cancer	0.000216	0.00181	CcSEcCtD
Disopyramide—Arrhythmia—Docetaxel—pancreatic cancer	0.000216	0.00181	CcSEcCtD
Disopyramide—Dyspnoea—Gemcitabine—pancreatic cancer	0.000216	0.00181	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000215	0.0018	CcSEcCtD
Disopyramide—Insomnia—Fluorouracil—pancreatic cancer	0.000215	0.0018	CcSEcCtD
Disopyramide—Somnolence—Gemcitabine—pancreatic cancer	0.000215	0.0018	CcSEcCtD
Disopyramide—Hypokalaemia—Epirubicin—pancreatic cancer	0.000214	0.0018	CcSEcCtD
Disopyramide—Fatigue—Irinotecan—pancreatic cancer	0.000214	0.00179	CcSEcCtD
Disopyramide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000213	0.00179	CcSEcCtD
Disopyramide—Pruritus—Sunitinib—pancreatic cancer	0.000213	0.00179	CcSEcCtD
Disopyramide—Constipation—Irinotecan—pancreatic cancer	0.000212	0.00178	CcSEcCtD
Disopyramide—Pain—Irinotecan—pancreatic cancer	0.000212	0.00178	CcSEcCtD
Disopyramide—Dyspnoea—Fluorouracil—pancreatic cancer	0.000212	0.00178	CcSEcCtD
Disopyramide—Somnolence—Fluorouracil—pancreatic cancer	0.000211	0.00177	CcSEcCtD
Disopyramide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00021	0.00176	CcSEcCtD
Disopyramide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000209	0.00176	CcSEcCtD
Disopyramide—Nausea—Tamoxifen—pancreatic cancer	0.000209	0.00175	CcSEcCtD
Disopyramide—Fatigue—Gemcitabine—pancreatic cancer	0.000208	0.00175	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—pancreatic cancer	0.000208	0.00174	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000207	0.00174	CcSEcCtD
Disopyramide—Pain—Gemcitabine—pancreatic cancer	0.000207	0.00173	CcSEcCtD
Disopyramide—Constipation—Gemcitabine—pancreatic cancer	0.000207	0.00173	CcSEcCtD
Disopyramide—Nausea—Erlotinib—pancreatic cancer	0.000207	0.00173	CcSEcCtD
Disopyramide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000207	0.00173	CcSEcCtD
Disopyramide—Diarrhoea—Sunitinib—pancreatic cancer	0.000206	0.00173	CcSEcCtD
Disopyramide—Dysgeusia—Docetaxel—pancreatic cancer	0.000206	0.00173	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—pancreatic cancer	0.000205	0.00172	CcSEcCtD
Disopyramide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000205	0.00172	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000204	0.00171	CcSEcCtD
Disopyramide—Pain—Fluorouracil—pancreatic cancer	0.000203	0.0017	CcSEcCtD
Disopyramide—Dizziness—Sunitinib—pancreatic cancer	0.000199	0.00167	CcSEcCtD
Disopyramide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000199	0.00167	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000199	0.00167	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000198	0.00166	CcSEcCtD
Disopyramide—Body temperature increased—Irinotecan—pancreatic cancer	0.000196	0.00165	CcSEcCtD
Disopyramide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000196	0.00164	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—pancreatic cancer	0.000192	0.00161	CcSEcCtD
Disopyramide—Vomiting—Sunitinib—pancreatic cancer	0.000192	0.00161	CcSEcCtD
Disopyramide—Body temperature increased—Gemcitabine—pancreatic cancer	0.000191	0.0016	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—pancreatic cancer	0.00019	0.0016	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—pancreatic cancer	0.00019	0.0016	CcSEcCtD
Disopyramide—Rash—Sunitinib—pancreatic cancer	0.00019	0.00159	CcSEcCtD
Disopyramide—Dermatitis—Sunitinib—pancreatic cancer	0.00019	0.00159	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—pancreatic cancer	0.00019	0.00159	CcSEcCtD
Disopyramide—Urticaria—Fluorouracil—pancreatic cancer	0.000189	0.00158	CcSEcCtD
Disopyramide—Headache—Sunitinib—pancreatic cancer	0.000189	0.00158	CcSEcCtD
Disopyramide—Syncope—Docetaxel—pancreatic cancer	0.000189	0.00158	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—pancreatic cancer	0.000188	0.00158	CcSEcCtD
Disopyramide—Body temperature increased—Fluorouracil—pancreatic cancer	0.000188	0.00158	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—pancreatic cancer	0.000185	0.00155	CcSEcCtD
Disopyramide—Loss of consciousness—Docetaxel—pancreatic cancer	0.000185	0.00155	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—pancreatic cancer	0.000181	0.00152	CcSEcCtD
Disopyramide—Chest pain—Docetaxel—pancreatic cancer	0.000179	0.0015	CcSEcCtD
Disopyramide—Nausea—Sunitinib—pancreatic cancer	0.000179	0.0015	CcSEcCtD
Disopyramide—Asthenia—Irinotecan—pancreatic cancer	0.000178	0.00149	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—pancreatic cancer	0.000176	0.00148	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—pancreatic cancer	0.000176	0.00148	CcSEcCtD
Disopyramide—Dry mouth—Docetaxel—pancreatic cancer	0.000175	0.00147	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—pancreatic cancer	0.000174	0.00146	CcSEcCtD
Disopyramide—Asthenia—Gemcitabine—pancreatic cancer	0.000173	0.00145	CcSEcCtD
Disopyramide—Confusional state—Docetaxel—pancreatic cancer	0.000173	0.00145	CcSEcCtD
Disopyramide—Oedema—Docetaxel—pancreatic cancer	0.000172	0.00144	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—pancreatic cancer	0.000171	0.00144	CcSEcCtD
Disopyramide—Pruritus—Gemcitabine—pancreatic cancer	0.000171	0.00143	CcSEcCtD
Disopyramide—Diarrhoea—Irinotecan—pancreatic cancer	0.00017	0.00142	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000169	0.00142	CcSEcCtD
Disopyramide—Shock—Docetaxel—pancreatic cancer	0.000169	0.00142	CcSEcCtD
Disopyramide—Pruritus—Fluorouracil—pancreatic cancer	0.000168	0.00141	CcSEcCtD
Disopyramide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000168	0.00141	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—pancreatic cancer	0.000168	0.00141	CcSEcCtD
Disopyramide—Skin disorder—Docetaxel—pancreatic cancer	0.000167	0.0014	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—pancreatic cancer	0.000166	0.00139	CcSEcCtD
Disopyramide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000165	0.00139	CcSEcCtD
Disopyramide—Dizziness—Irinotecan—pancreatic cancer	0.000164	0.00138	CcSEcCtD
Disopyramide—Anorexia—Docetaxel—pancreatic cancer	0.000164	0.00137	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—pancreatic cancer	0.000163	0.00137	CcSEcCtD
Disopyramide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000163	0.00136	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000162	0.00136	CcSEcCtD
Disopyramide—Hypotension—Docetaxel—pancreatic cancer	0.00016	0.00134	CcSEcCtD
Disopyramide—Vomiting—Irinotecan—pancreatic cancer	0.000158	0.00132	CcSEcCtD
Disopyramide—Dizziness—Fluorouracil—pancreatic cancer	0.000157	0.00132	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000157	0.00131	CcSEcCtD
Disopyramide—Rash—Irinotecan—pancreatic cancer	0.000157	0.00131	CcSEcCtD
Disopyramide—Dermatitis—Irinotecan—pancreatic cancer	0.000156	0.00131	CcSEcCtD
Disopyramide—CHRM3—digestive system—pancreatic cancer	0.000156	0.0372	CbGeAlD
Disopyramide—Headache—Irinotecan—pancreatic cancer	0.000156	0.0013	CcSEcCtD
Disopyramide—Insomnia—Docetaxel—pancreatic cancer	0.000155	0.0013	CcSEcCtD
Disopyramide—Paraesthesia—Docetaxel—pancreatic cancer	0.000154	0.00129	CcSEcCtD
Disopyramide—Vomiting—Gemcitabine—pancreatic cancer	0.000154	0.00129	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—pancreatic cancer	0.000153	0.00129	CcSEcCtD
Disopyramide—Dyspnoea—Docetaxel—pancreatic cancer	0.000153	0.00128	CcSEcCtD
Disopyramide—Somnolence—Docetaxel—pancreatic cancer	0.000153	0.00128	CcSEcCtD
Disopyramide—Rash—Gemcitabine—pancreatic cancer	0.000152	0.00128	CcSEcCtD
Disopyramide—Dermatitis—Gemcitabine—pancreatic cancer	0.000152	0.00128	CcSEcCtD
Disopyramide—Headache—Gemcitabine—pancreatic cancer	0.000151	0.00127	CcSEcCtD
Disopyramide—Vomiting—Fluorouracil—pancreatic cancer	0.000151	0.00127	CcSEcCtD
Disopyramide—Dyspepsia—Docetaxel—pancreatic cancer	0.000151	0.00127	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—pancreatic cancer	0.000151	0.00126	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00015	0.00126	CcSEcCtD
Disopyramide—Rash—Fluorouracil—pancreatic cancer	0.00015	0.00126	CcSEcCtD
Disopyramide—Dermatitis—Fluorouracil—pancreatic cancer	0.00015	0.00126	CcSEcCtD
Disopyramide—Decreased appetite—Docetaxel—pancreatic cancer	0.000149	0.00125	CcSEcCtD
Disopyramide—Headache—Fluorouracil—pancreatic cancer	0.000149	0.00125	CcSEcCtD
Disopyramide—Fatigue—Docetaxel—pancreatic cancer	0.000148	0.00124	CcSEcCtD
Disopyramide—Nausea—Irinotecan—pancreatic cancer	0.000147	0.00124	CcSEcCtD
Disopyramide—Constipation—Docetaxel—pancreatic cancer	0.000147	0.00123	CcSEcCtD
Disopyramide—Pain—Docetaxel—pancreatic cancer	0.000147	0.00123	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—pancreatic cancer	0.000146	0.00122	CcSEcCtD
Disopyramide—Nausea—Gemcitabine—pancreatic cancer	0.000144	0.0012	CcSEcCtD
Disopyramide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000141	0.00119	CcSEcCtD
Disopyramide—Nausea—Fluorouracil—pancreatic cancer	0.000141	0.00118	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—pancreatic cancer	0.00014	0.00117	CcSEcCtD
Disopyramide—Tension—Epirubicin—pancreatic cancer	0.000139	0.00117	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—pancreatic cancer	0.000139	0.00116	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—pancreatic cancer	0.000138	0.00116	CcSEcCtD
Disopyramide—Body temperature increased—Docetaxel—pancreatic cancer	0.000136	0.00114	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—pancreatic cancer	0.000135	0.00113	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—pancreatic cancer	0.000134	0.00112	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000132	0.0011	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—pancreatic cancer	0.000129	0.00108	CcSEcCtD
Disopyramide—Tension—Doxorubicin—pancreatic cancer	0.000129	0.00108	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000128	0.00108	CcSEcCtD
Disopyramide—Malaise—Epirubicin—pancreatic cancer	0.000128	0.00107	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—pancreatic cancer	0.000127	0.00107	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—pancreatic cancer	0.000127	0.00107	CcSEcCtD
Disopyramide—Syncope—Epirubicin—pancreatic cancer	0.000127	0.00107	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000125	0.00105	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—pancreatic cancer	0.000124	0.00104	CcSEcCtD
Disopyramide—Asthenia—Docetaxel—pancreatic cancer	0.000123	0.00103	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000122	0.00102	CcSEcCtD
Disopyramide—Pruritus—Docetaxel—pancreatic cancer	0.000121	0.00102	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—pancreatic cancer	0.000121	0.00101	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—pancreatic cancer	0.000119	0.001	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—pancreatic cancer	0.000118	0.000992	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—pancreatic cancer	0.000118	0.00099	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—pancreatic cancer	0.000118	0.000989	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—pancreatic cancer	0.000118	0.000987	CcSEcCtD
Disopyramide—Diarrhoea—Docetaxel—pancreatic cancer	0.000117	0.000985	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—pancreatic cancer	0.000117	0.000979	CcSEcCtD
Disopyramide—Oedema—Epirubicin—pancreatic cancer	0.000116	0.000971	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000115	0.000967	CcSEcCtD
Disopyramide—Shock—Epirubicin—pancreatic cancer	0.000114	0.000955	CcSEcCtD
Disopyramide—Dizziness—Docetaxel—pancreatic cancer	0.000113	0.000952	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000113	0.00095	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—pancreatic cancer	0.000112	0.000943	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000112	0.000938	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—pancreatic cancer	0.000112	0.000937	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—pancreatic cancer	0.00011	0.000926	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—pancreatic cancer	0.00011	0.000925	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—pancreatic cancer	0.000109	0.000916	CcSEcCtD
Disopyramide—Vomiting—Docetaxel—pancreatic cancer	0.000109	0.000915	CcSEcCtD
Disopyramide—Rash—Docetaxel—pancreatic cancer	0.000108	0.000907	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—pancreatic cancer	0.000108	0.000907	CcSEcCtD
Disopyramide—Dermatitis—Docetaxel—pancreatic cancer	0.000108	0.000906	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—pancreatic cancer	0.000108	0.000906	CcSEcCtD
Disopyramide—Headache—Docetaxel—pancreatic cancer	0.000107	0.000901	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—pancreatic cancer	0.000107	0.000898	CcSEcCtD
Disopyramide—Shock—Doxorubicin—pancreatic cancer	0.000105	0.000884	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000105	0.000879	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—pancreatic cancer	0.000105	0.000878	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—pancreatic cancer	0.000104	0.000872	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—pancreatic cancer	0.000104	0.000872	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000104	0.000868	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—pancreatic cancer	0.000103	0.000865	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—pancreatic cancer	0.000103	0.000863	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—pancreatic cancer	0.000102	0.000856	CcSEcCtD
Disopyramide—Nausea—Docetaxel—pancreatic cancer	0.000102	0.000855	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—pancreatic cancer	0.000102	0.000854	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—pancreatic cancer	0.000101	0.000844	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—pancreatic cancer	0.0001	0.000839	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—pancreatic cancer	9.98e-05	0.000837	CcSEcCtD
Disopyramide—Constipation—Epirubicin—pancreatic cancer	9.9e-05	0.00083	CcSEcCtD
Disopyramide—Pain—Epirubicin—pancreatic cancer	9.9e-05	0.00083	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—pancreatic cancer	9.69e-05	0.000812	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—pancreatic cancer	9.62e-05	0.000806	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—pancreatic cancer	9.55e-05	0.000801	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—pancreatic cancer	9.54e-05	0.0008	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—pancreatic cancer	9.52e-05	0.000798	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—pancreatic cancer	9.43e-05	0.000791	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—pancreatic cancer	9.31e-05	0.000781	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—pancreatic cancer	9.23e-05	0.000774	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—pancreatic cancer	9.19e-05	0.000771	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—pancreatic cancer	9.16e-05	0.000768	CcSEcCtD
Disopyramide—Pain—Doxorubicin—pancreatic cancer	9.16e-05	0.000768	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—pancreatic cancer	9.15e-05	0.000767	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—pancreatic cancer	8.82e-05	0.00074	CcSEcCtD
Disopyramide—CYP3A4—digestive system—pancreatic cancer	8.58e-05	0.0204	CbGeAlD
Disopyramide—Urticaria—Doxorubicin—pancreatic cancer	8.51e-05	0.000713	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—pancreatic cancer	8.47e-05	0.00071	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—pancreatic cancer	8.3e-05	0.000696	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—pancreatic cancer	8.19e-05	0.000687	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—pancreatic cancer	7.92e-05	0.000664	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—pancreatic cancer	7.68e-05	0.000644	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—pancreatic cancer	7.65e-05	0.000642	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—pancreatic cancer	7.58e-05	0.000635	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—pancreatic cancer	7.36e-05	0.000617	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—pancreatic cancer	7.33e-05	0.000614	CcSEcCtD
Disopyramide—Rash—Epirubicin—pancreatic cancer	7.3e-05	0.000612	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—pancreatic cancer	7.29e-05	0.000611	CcSEcCtD
Disopyramide—Headache—Epirubicin—pancreatic cancer	7.25e-05	0.000608	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—pancreatic cancer	7.08e-05	0.000594	CcSEcCtD
Disopyramide—Nausea—Epirubicin—pancreatic cancer	6.87e-05	0.000577	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—pancreatic cancer	6.81e-05	0.000571	CcSEcCtD
Disopyramide—Rash—Doxorubicin—pancreatic cancer	6.75e-05	0.000566	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—pancreatic cancer	6.75e-05	0.000566	CcSEcCtD
Disopyramide—Headache—Doxorubicin—pancreatic cancer	6.71e-05	0.000563	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—pancreatic cancer	6.36e-05	0.000533	CcSEcCtD
Disopyramide—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	1.42e-05	0.000425	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	1.41e-05	0.000421	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	1.41e-05	0.000421	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	1.41e-05	0.000421	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCKAR—pancreatic cancer	1.4e-05	0.00042	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	1.4e-05	0.000418	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—HRAS—pancreatic cancer	1.39e-05	0.000417	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	1.38e-05	0.000414	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GCG—pancreatic cancer	1.37e-05	0.000409	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JAG2—pancreatic cancer	1.36e-05	0.000407	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	1.36e-05	0.000405	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	1.34e-05	0.000402	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MEN1—pancreatic cancer	1.34e-05	0.000401	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	1.34e-05	0.0004	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CD44—pancreatic cancer	1.33e-05	0.000398	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	1.32e-05	0.000396	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—HRAS—pancreatic cancer	1.3e-05	0.000389	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—AKT1—pancreatic cancer	1.29e-05	0.000385	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—STK11—pancreatic cancer	1.29e-05	0.000385	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SHH—pancreatic cancer	1.28e-05	0.000382	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GCG—pancreatic cancer	1.28e-05	0.000381	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SHH—pancreatic cancer	1.27e-05	0.000381	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH4—pancreatic cancer	1.27e-05	0.00038	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	1.27e-05	0.000379	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IAPP—pancreatic cancer	1.26e-05	0.000378	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SHH—pancreatic cancer	1.26e-05	0.000378	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	1.26e-05	0.000377	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	1.25e-05	0.000375	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	1.25e-05	0.000373	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CD44—pancreatic cancer	1.23e-05	0.000368	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTHLH—pancreatic cancer	1.21e-05	0.000363	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTCH1—pancreatic cancer	1.21e-05	0.000363	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	1.21e-05	0.000361	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	1.21e-05	0.000361	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—STK11—pancreatic cancer	1.2e-05	0.000359	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	1.2e-05	0.000358	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	1.2e-05	0.000358	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GCG—pancreatic cancer	1.18e-05	0.000352	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SST—pancreatic cancer	1.11e-05	0.000332	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—STK11—pancreatic cancer	1.11e-05	0.000331	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TYMS—pancreatic cancer	1.11e-05	0.000331	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SST—pancreatic cancer	1.1e-05	0.000331	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SST—pancreatic cancer	1.09e-05	0.000327	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.09e-05	0.000327	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.09e-05	0.000326	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.09e-05	0.000325	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	1.08e-05	0.000325	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	1.08e-05	0.000323	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	1.08e-05	0.000323	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.08e-05	0.000323	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	1.08e-05	0.000322	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	1.07e-05	0.00032	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	1.07e-05	0.000319	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TYMS—pancreatic cancer	1.03e-05	0.000308	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	1.02e-05	0.000306	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	1.02e-05	0.000305	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	1.01e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	9.93e-06	0.000297	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	9.9e-06	0.000296	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GCG—pancreatic cancer	9.88e-06	0.000296	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GCG—pancreatic cancer	9.85e-06	0.000295	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	9.8e-06	0.000293	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GCG—pancreatic cancer	9.75e-06	0.000292	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.61e-06	0.000288	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.58e-06	0.000287	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TYMS—pancreatic cancer	9.53e-06	0.000285	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.49e-06	0.000284	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.43e-06	0.000282	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	9.43e-06	0.000282	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	9.4e-06	0.000281	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	9.3e-06	0.000278	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STK11—pancreatic cancer	9.29e-06	0.000278	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STK11—pancreatic cancer	9.26e-06	0.000277	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STK11—pancreatic cancer	9.17e-06	0.000274	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOE—pancreatic cancer	9e-06	0.000269	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	8.73e-06	0.000261	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	8.7e-06	0.00026	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	8.62e-06	0.000258	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOE—pancreatic cancer	8.39e-06	0.000251	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.38e-06	0.000251	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.35e-06	0.00025	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.27e-06	0.000247	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.24e-06	0.000247	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	8.14e-06	0.000243	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	8.12e-06	0.000243	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	8.11e-06	0.000243	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	8.05e-06	0.000241	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	8.03e-06	0.00024	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	8.02e-06	0.00024	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	7.95e-06	0.000238	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HES1—pancreatic cancer	7.94e-06	0.000238	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HES1—pancreatic cancer	7.92e-06	0.000237	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HES1—pancreatic cancer	7.84e-06	0.000235	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—pancreatic cancer	7.84e-06	0.000234	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—pancreatic cancer	7.75e-06	0.000232	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.61e-06	0.000228	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	7.58e-06	0.000227	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	7.57e-06	0.000226	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	7.51e-06	0.000225	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	7.31e-06	0.000219	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—pancreatic cancer	7.31e-06	0.000219	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	7.29e-06	0.000218	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	7.22e-06	0.000216	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	7.14e-06	0.000214	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CG—pancreatic cancer	6.99e-06	0.000209	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TERT—pancreatic cancer	6.96e-06	0.000208	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TERT—pancreatic cancer	6.94e-06	0.000208	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TERT—pancreatic cancer	6.87e-06	0.000206	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—pancreatic cancer	6.75e-06	0.000202	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	6.66e-06	0.000199	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	6.65e-06	0.000199	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.64e-06	0.000199	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	6.64e-06	0.000199	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	6.64e-06	0.000199	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	6.62e-06	0.000198	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	6.57e-06	0.000197	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	6.56e-06	0.000196	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.54e-06	0.000196	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—pancreatic cancer	6.5e-06	0.000194	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—pancreatic cancer	6.48e-06	0.000194	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—pancreatic cancer	6.41e-06	0.000192	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KDR—pancreatic cancer	6.37e-06	0.00019	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KDR—pancreatic cancer	6.35e-06	0.00019	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KDR—pancreatic cancer	6.28e-06	0.000188	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	6.22e-06	0.000186	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.2e-06	0.000186	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—pancreatic cancer	6.17e-06	0.000184	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CD—pancreatic cancer	6.15e-06	0.000184	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	6.06e-06	0.000181	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	6.04e-06	0.000181	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	6e-06	0.000179	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	5.98e-06	0.000179	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	5.98e-06	0.000179	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	5.92e-06	0.000177	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	5.86e-06	0.000175	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	5.86e-06	0.000175	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	5.85e-06	0.000175	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	5.85e-06	0.000175	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	5.8e-06	0.000174	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGF—pancreatic cancer	5.8e-06	0.000173	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	5.79e-06	0.000173	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	5.79e-06	0.000173	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGF—pancreatic cancer	5.78e-06	0.000173	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—pancreatic cancer	5.75e-06	0.000172	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGF—pancreatic cancer	5.72e-06	0.000171	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTEN—pancreatic cancer	5.38e-06	0.000161	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CB—pancreatic cancer	5.36e-06	0.00016	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	5.34e-06	0.00016	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	5.33e-06	0.000159	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—pancreatic cancer	5.31e-06	0.000159	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	5.27e-06	0.000158	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	5.16e-06	0.000154	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	5.14e-06	0.000154	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.11e-06	0.000153	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.09e-06	0.000152	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	5.09e-06	0.000152	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	5.05e-06	0.000151	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.04e-06	0.000151	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	5.03e-06	0.000151	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTEN—pancreatic cancer	5.01e-06	0.00015	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	4.98e-06	0.000149	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CD44—pancreatic cancer	4.8e-06	0.000144	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.64e-06	0.000139	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTEN—pancreatic cancer	4.63e-06	0.000138	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	4.62e-06	0.000138	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCG—pancreatic cancer	4.6e-06	0.000138	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.58e-06	0.000137	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	4.49e-06	0.000134	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	4.48e-06	0.000134	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	4.44e-06	0.000133	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—STK11—pancreatic cancer	4.33e-06	0.00013	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	4.32e-06	0.000129	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	4.3e-06	0.000129	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	4.29e-06	0.000128	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	4.28e-06	0.000128	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	4.26e-06	0.000128	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	4.24e-06	0.000127	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	4.17e-06	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	4.16e-06	0.000124	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	4.13e-06	0.000124	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	4.12e-06	0.000123	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	4.12e-06	0.000123	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	4.08e-06	0.000122	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	4.02e-06	0.00012	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	4.01e-06	0.00012	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.98e-06	0.000119	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3.97e-06	0.000119	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.97e-06	0.000119	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.93e-06	0.000118	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	3.91e-06	0.000117	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	3.89e-06	0.000116	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	3.88e-06	0.000116	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	3.87e-06	0.000116	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.86e-06	0.000115	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.83e-06	0.000115	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	3.79e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.79e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	3.78e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	3.74e-06	0.000112	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.72e-06	0.000111	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SRC—pancreatic cancer	3.6e-06	0.000108	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SRC—pancreatic cancer	3.59e-06	0.000107	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.55e-06	0.000106	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	3.54e-06	0.000106	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3.51e-06	0.000105	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	3.5e-06	0.000105	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	3.47e-06	0.000104	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	3.46e-06	0.000104	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.46e-06	0.000104	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	3.46e-06	0.000104	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	3.45e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.43e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.42e-06	0.000102	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—pancreatic cancer	3.27e-06	9.77e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—pancreatic cancer	3.23e-06	9.65e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	3.22e-06	9.63e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—pancreatic cancer	3.22e-06	9.62e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	3.21e-06	9.6e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3.19e-06	9.53e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3.18e-06	9.51e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	3.16e-06	9.44e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	3.15e-06	9.41e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	3.12e-06	9.32e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—pancreatic cancer	3.1e-06	9.27e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—pancreatic cancer	3.03e-06	9.06e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.98e-06	8.92e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.97e-06	8.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.94e-06	8.81e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—pancreatic cancer	2.89e-06	8.64e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.74e-06	8.2e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.73e-06	8.18e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.73e-06	8.17e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.7e-06	8.09e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—pancreatic cancer	2.67e-06	7.98e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.65e-06	7.93e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.64e-06	7.9e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.64e-06	7.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.62e-06	7.83e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.53e-06	7.58e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.53e-06	7.56e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.5e-06	7.48e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.4e-06	7.19e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.24e-06	6.7e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.23e-06	6.67e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.21e-06	6.61e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	6.27e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.08e-06	6.21e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.81e-06	5.41e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.28e-06	3.82e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.04e-06	3.12e-05	CbGpPWpGaD
